Press "Enter" to skip to content

New patent expiration for Novartis drug LESCOL XL

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug LESCOL XL

Annual Drug Patent Expirations for LESCOL+XL
Annual Drug Patent Expirations for LESCOL+XL

Lescol Xl is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

LESCOL XL drug price trends.

Drug patent litigation for LESCOL XL.

The generic ingredient in LESCOL XL is fluvastatin sodium. Two suppliers are listed for this compound. Additional details are available on the fluvastatin sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug LESCOL XL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!